Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: Results from the national cancer data base

International Journal of Radiation Oncology Biology Physics

Volumn 88, Issue 5, 2014, Pages 1048-1056

  Gray, Phillip J ^a,b   Lin, Chun Chieh ^c   Jemal, Ahmedin ^c   Shipley, William U ^a   Fedewa, Stacey A ^c   Kibel, Adam S ^d   Rosenberg, Jonathan E ^e   Kamat, Ashish M ^f   Virgo, Katherine S ^g   Blute, Michael L ^a   Zietman, Anthony L ^a   Efstathiou, Jason A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COX PROPORTIONAL HAZARDS MODELS; DISTANT METASTASIS; GENERALIZED ESTIMATING EQUATIONS; KAPLAN-MEIER METHOD; MANAGEMENT STRATEGIES; METHODS AND MATERIALS; MULTI VARIATE ANALYSIS; OVERALL SURVIVAL RATES;

CHEMOTHERAPY; DISEASES; PATHOLOGY; PATIENT MONITORING;

PATIENT TREATMENT;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CENTER; CANCER DIAGNOSIS; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; DATA BASE; DISTANT METASTASIS; FEMALE; HISPANIC; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATIONAL HEALTH ORGANIZATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

AGED; AGED, 80 AND OVER; CYSTECTOMY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 84897872564     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.01.001     Document Type: Article

References (34)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. H.W. Herr, D.M. Schwalb, and Z.F. Zhang et al. Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: Ten-year follow-up of a prospective randomized trial J Clin Oncol 13 1995 1404 1408
3. P.J. Gray, S.A. Fedewa, and W.U. Shipley et al. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: Results from the National Cancer Data Base Eur Urol 63 2013 823 829
4. J.A. Efstathiou, D.Y. Spiegel, and W.U. Shipley et al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: The MGH experience Eur Urol 61 2012 705 711
5. N.D. James, S.A. Hussain, and E. Hall et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer N Engl J Med 366 2012 1477 1488
6. C. Rodel, G.G. Grabenbauer, and R. Kuhn et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results J Clin Oncol 20 2002 3061 3071
7. R.S. Svatek, S.F. Shariat, and G. Novara et al. Discrepancy between clinical and pathological stage: External validation of the impact on prognosis in an international radical cystectomy cohort BJU Int 107 2011 898 904
8. D. Canter, C. Long, and A. Kutikov et al. Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: Further evidence to support the use of neoadjuvant chemotherapy BJU Int 107 2011 58 62
9. M. Ploeg, L.A. Kiemeney, and G.A. Smits et al. Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy Urol Oncol 30 2012 247 251
10. S. McLaughlin, J. Shephard, and E. Wallen et al. Comparison of the clinical and pathologic staging in patients undergoing radical cystectomy for bladder cancer Int Braz J Urol 33 2007 25 31 discussion 31-22
11. M.E. Nielsen, S.F. Shariat, and P.I. Karakiewicz et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy Eur Urol 51 2007 699 706 discussion 706-698
12. S.F. Shariat, G.S. Palapattu, and P.I. Karakiewicz et al. Discrepancy between clinical and pathologic stage: Impact on prognosis after radical cystectomy Eur Urol 51 2007 137 149 discussion 149-151
13. S.C. Dutta, J.A. Smith Jr., and S.B. Shappell et al. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy J Urol 166 2001 490 493
14. F. Pagano, P. Bassi, and T.P. Galetti et al. Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification J Urol 145 1991 45 50
15. C.A. Goossens-Laan, O. Visser, and M.C. Hulshof et al. Survival after treatment for carcinoma invading bladder muscle: A Dutch population-based study on the impact of hospital volume BJU Int 110 2012 226 232
16. B.K. Hollenbeck, S. Daignault, and R.L. Dunn et al. Getting under the hood of the volume-outcome relationship for radical cystectomy J Urol 177 2007 2095 2099 discussion 2099
17. K.Y. Bilimoria, D.J. Bentrem, and A.K. Stewart et al. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: Implications for studies that use the National Cancer Data Base J Clin Oncol 27 2009 4177 4181
18. U. Fedeli, S.A. Fedewa, and E.M. Ward Treatment of muscle invasive bladder cancer: Evidence from the National Cancer Database, 2003 to 2007 J Urol 185 2011 72 78
19. US Census Regions; 2012. p. https://www.census.gov/geo/www/us-regdiv.pdf.
20. S.A. Fedewa, E.M. Ward, and A.K. Stewart et al. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: A national cohort study 2004-2006 J Clin Oncol 28 2010 4135 4141
21. V. Ficarra, O. Dalpiaz, and N. Alrabi et al. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma BJU Int 95 2005 786 790
22. B.K. Hollenbeck, D.C. Miller, and R.L. Dunn et al. The effects of stage divergence on survival after radical cystectomy for urothelial cancer Urol Oncol 23 2005 77 81
23. P. Turker, P.J. Bostrom, and M.L. Wroclawski et al. Upstaging of urothelial cancer at the time of radical cystectomy: Factors associated with upstaging and its effect on outcome BJU Int 110 2012 804 811
24. A.P. Mitra, E.C. Skinner, and G. Miranda et al. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer BJU Int 111 2013 240 248
25. E.K. Johnson, S. Daignault, and Y. Zhang et al. Patterns of hematuria referral to urologists: Does a gender disparity exist? Urology 72 2008 498 502 discussion 502-503
26. S. Daneshmand, H. Ahmadi, and L.N. Huynh et al. Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: Results from a prospective study Urology 80 2012 1313 1318
27. W. Kassouf, P.E. Spiess, and G.A. Brown et al. P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors Eur Urol 52 2007 769 774
28. M. Manoharan, R. Ayyathurai, and R. de Los Santos et al. Presentation and outcome following radical cystectomy in Hispanics with bladder cancer Int Braz J Urol 34 2008 691 698 discussion 698
29. E. Scosyrev, K. Noyes, and C. Feng et al. Sex and racial differences in bladder cancer presentation and mortality in the US Cancer 115 2009 68 74
30. J.L. Wright, D.W. Lin, and M.P. Porter The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy Cancer 112 2008 2401 2408
31. H.W. Herr, B.H. Bochner, and G. Dalbagni et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer J Urol 167 2002 1295 1298
32. H.B. Grossman, R.B. Natale, and C.M. Tangen et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859 866
33. G. Griffiths, R. Hall, and R. Sylvester et al. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: Long-term results of the BA06 30894 trial J Clin Oncol 29 2011 2171 2177
34. C.J. Weight, J.A. Garcia, and D.E. Hansel et al. Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: A contemporary series Cancer 115 2009 792 799